Literature DB >> 20957518

Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up.

Peter Bernhardt1, Sascha Stiller, Eva Kottmair, Ludwig Binner, Jochen Spiess, Georg Grossmann, Volker Rasche, Daniel Walcher, Vinzenz Hombach.   

Abstract

Patients with ischemic cardiomyopathy have an increased risk for ventricular arrhythmia, since myocardial infarction can be the substrate for re-entrant arrhythmias. Contrast-enhanced cardiac magnetic resonance imaging (CMR) has proven to reliably quantify myocardial infarction. Aim of our study was to evaluate correlations between functional and contrast-enhanced CMR findings and spontaneous ventricular tachy-arrhythmias in patients with ischemic cardiomyopathy who underwent implantable cardioverter-defibrillator (ICD) therapy. Forty-one patients with ischemic cardiomyopathy and indication for ICD therapy underwent cine and late gadolinium enhancement CMR for quantification of left ventricular volumes, function and scar tissue before subsequent implantation of ICD device. During a follow-up period of 1184 ± 442 days 68 monomorphic and 14 polymorphic types of ventricular tachycardia (VT) could be observed in 12 patients. Patients with monomorphic VT had larger scar volumes (25.3 ± 11.3 vs. 11.8 ± 7.5% of myocardial mass, P < 0.05) than patients with polymorphic VT. Moreover myocardial infarction involved more segments in the LAD perfusion territory (86 vs. 20%, P < 0.05) than in patients with polymorphic VT. Patients with spontaneous monomorphic VT during the long-term follow-up period had more infarcted tissue, which was more often present in the LAD perfusion territory than patients with polymorphic events. These data strengthen the diagnostic benefit of CMR in patients with ischemic cardiomyopathy. CMR may be used for better risk stratification in patients with ischemic cardiomyopathy undergoing ICD therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957518     DOI: 10.1007/s10554-010-9726-9

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  27 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

Review 2.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

3.  Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping.

Authors:  W G Stevenson; P L Friedman; P T Sager; L A Saxon; D Kocovic; T Harada; I Wiener; H Khan
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

4.  Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.

Authors:  Stijntje D Roes; C Jan Willem Borleffs; Rob J van der Geest; Jos J M Westenberg; Nina Ajmone Marsan; Theodorus A M Kaandorp; Johan H C Reiber; Katja Zeppenfeld; Hildo J Lamb; Albert de Roos; Martin J Schalij; Jeroen J Bax
Journal:  Circ Cardiovasc Imaging       Date:  2009-03-23       Impact factor: 7.792

5.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

6.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model.

Authors:  Luciano C Amado; Bernhard L Gerber; Sandeep N Gupta; Dan W Rettmann; Gilberto Szarf; Robert Schock; Khurram Nasir; Dara L Kraitchman; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2004-12-21       Impact factor: 24.094

8.  Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction.

Authors:  Olaf Grebe; Ingo Paetsch; Hans A Kestler; Bernhard Herkommer; Bernhard Schnackenburg; Vinzenz Hombach; Eckart Fleck; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2003       Impact factor: 5.364

9.  A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.

Authors:  J W Mason
Journal:  N Engl J Med       Date:  1993-08-12       Impact factor: 91.245

10.  Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate.

Authors:  Frank M Bogun; Benoit Desjardins; Eric Good; Sanjaya Gupta; Thomas Crawford; Hakan Oral; Matthew Ebinger; Frank Pelosi; Aman Chugh; Krit Jongnarangsin; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2009-03-31       Impact factor: 24.094

View more
  6 in total

1.  Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.

Authors:  Tawfiq Zeidan-Shwiri; Yuesong Yang; Ilan Lashevsky; Ehud Kadmon; Darren Kagal; Alexander Dick; Avishag Laish Farkash; Gideon Paul; Donsheng Gao; Mohammed Shurrab; David Newman; Graham Wright; Eugene Crystal
Journal:  Heart Rhythm       Date:  2015-01-09       Impact factor: 6.343

2.  Virtual electrophysiological study in a 3-dimensional cardiac magnetic resonance imaging model of porcine myocardial infarction.

Authors:  Jason Ng; Jason T Jacobson; Justin K Ng; David Gordon; Daniel C Lee; James C Carr; Jeffrey J Goldberger
Journal:  J Am Coll Cardiol       Date:  2012-05-23       Impact factor: 24.094

Review 3.  Cardiovascular imaging 2011 in the International Journal of Cardiovascular Imaging.

Authors:  Ricardo A Costa; Hiram G Bezerra; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2012-03       Impact factor: 2.357

4.  Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease.

Authors:  Yuesong Yang; Kim A Connelly; Tawfiq Zeidan-Shwiri; Yingli Lu; Gideon Paul; Idan Roifman; Mohammad I Zia; John J Graham; Alexander J Dick; Eugene Crystal; Graham A Wright
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-26       Impact factor: 5.364

5.  Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.

Authors:  Joachim Alexandre; Eric Saloux; Audrey Emmanuelle Dugué; Alain Lebon; Adrien Lemaitre; Vincent Roule; Fabien Labombarda; Nicole Provost; Sophie Gomes; Patrice Scanu; Paul Milliez
Journal:  J Cardiovasc Magn Reson       Date:  2013-01-19       Impact factor: 5.364

6.  Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review.

Authors:  Godefroy Chery; Nicholas Kamp; Andrzej S Kosinski; Gillian Sanders Schmidler; Renato D Lopes; Manesh Patel; Sana M Al-Khatib
Journal:  Am Heart J       Date:  2020-08-11       Impact factor: 4.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.